AbbVie

Open: 154.54 Close: 154.97 Change: 0.43

The top 10 things about AbbVie Company Inc Stock found by an AI.

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

HSBC downgraded shares of AbbVie from a buy rating to a hold rating. HSBC downgrades shares of ABbV to hold rating on Monday morning. ABbvie possesses a ZACK Rank of #3 (Hold)

Today's News

AbbVie inc. stock rises friday, outperforms market - marketwatch. abbvie inc., stock rises. friday. AbbVie Inc. has announced its acquisition of ImmunoGen for $10.1 billion in cash. Coca-Cola stock is down 10% this year. We discuss why we believe KO will offer higher returns than ABBV. The Treasury and Risk Management Application Lead will conceive, design, engineer, and implement technology solutions that solve Treasury and Financial needs. HSBC downgraded shares of AbbVie from a buy rating to a hold rating. HSBC downgrades shares of ABbV to hold rating on Monday morning. AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. The mean historical PE ratio of ABBVie over the last ten years is 26.08. ABbVies recent ImmunoGen acquisition Looks Brilliant: Heres Why. AbbVie Inc. technical shift lead at abbvie. Technical Shift Lead at ABBVIE. Strong communication skills in both verbal and written. Strong interpersonal skills required. AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion. $19 billion in a week: Abbvie makes two Big Pharma deals in one week. $10.1 billion takeover of ImmunoGen, Cancer drug maker, in $10 billion deal. Accountant will be responsible for reconciling AbbVie Workday Accounting records vs payroll payment processed by ADP. AbbVie is seeking a highly motivated, experienced analytical scientist and leader to lead a team of analytical scientists supporting the development of New Chemical Entities (NCEs) drug substance and drug product. AbbVie possesses a Zacks Rank of #3 (Hold) Right now, Abbvie possesses an average ZACK Rank of 3 (Hold). The investment community will be paying close attention.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, ImmunoGen, rating, drug, inc, rise, and the most common words in the summary are: abbvie, stock, inc, market, abbv, option, price, . One of the sentences in the summary was: HSBC downgrades shares of ABbV to hold rating on Monday morning. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #inc #market #abbv #option #price.